Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore.

MLA

Soh, Xin Qin, et al. “Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: An Asian Cohort Study from Singapore.” Cardiovascular Drugs and Therapy, vol. 37, no. 5, Oct. 2023, pp. 917–25. EBSCOhost, https://doi.org/10.1007/s10557-022-07346-8.

APA

Soh, X. Q., Tan, D. S.-Y., & Chan, E. C. Y. (2023). Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore. Cardiovascular Drugs and Therapy, 37(5), 917–925. https://doi.org/10.1007/s10557-022-07346-8

Chicago

Soh, Xin Qin, Doreen Su-Yin Tan, and Eric Chun Yong Chan. 2023. “Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: An Asian Cohort Study from Singapore.” Cardiovascular Drugs and Therapy 37 (5): 917–25. doi:10.1007/s10557-022-07346-8.